Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bungaro

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Leukemia|April 28, 2017
Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia clusterG Cazzaniga, L Bisanti, G Randi, et al.
Minerva Urology and Nephrology|February 11, 2022
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective studyTiziana Angusti, Rosario F DI Stefano, Antonella Parente, et al.
Prostate Cancer and Prostatic Diseases|February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetateRosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Leukemia|August 27, 2005
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patientsR G Piazza, V Magistroni, F Andreoni, et al.
Minerva Urology and Nephrology|March 30, 2021
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamideChiara Pisano, Marcello Tucci, Rosario F DI Stefano, et al.
ESMO Open|October 13, 2022
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020C Paratore, C Zichi, M Audisio, et al.
Leukemia|November 13, 2009
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4M Bardini, R Spinelli, S Bungaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patientsCarlo Gambacorti-Passerini, Massimo Zucchetti, Domenico Russo, et al.
Orthopedics|July 1, 1996
A technical report reviewing the use of the 11-mm Gamma nail: interoperative femur fracture incidenceS Boriani, F De Iure, L Campanacci, et al.
Genes, Chromosomes & Cancer|September 23, 2008
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarksSilvia Bungaro, Marta Campo Dell'Orto, Andrea Zangrando, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Leukemia|April 28, 2017
Possible role of pandemic AH1N1 swine flu virus in a childhood leukemia clusterG Cazzaniga, L Bisanti, G Randi, et al.
Minerva Urology and Nephrology|February 11, 2022
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective studyTiziana Angusti, Rosario F DI Stefano, Antonella Parente, et al.
Prostate Cancer and Prostatic Diseases|February 19, 2021
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetateRosario F Di Stefano, Marcello Tucci, Fabio Turco, et al.
Leukemia|August 27, 2005
Imatinib dose increase up to 1200 mg daily can induce new durable complete cytogenetic remissions in relapsed Ph+ chronic myeloid leukemia patientsR G Piazza, V Magistroni, F Andreoni, et al.
Minerva Urology and Nephrology|March 30, 2021
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamideChiara Pisano, Marcello Tucci, Rosario F DI Stefano, et al.
ESMO Open|October 13, 2022
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020C Paratore, C Zichi, M Audisio, et al.
Leukemia|November 13, 2009
DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4M Bardini, R Spinelli, S Bungaro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Alpha1 acid glycoprotein binds to imatinib (STI571) and substantially alters its pharmacokinetics in chronic myeloid leukemia patientsCarlo Gambacorti-Passerini, Massimo Zucchetti, Domenico Russo, et al.
Orthopedics|July 1, 1996
A technical report reviewing the use of the 11-mm Gamma nail: interoperative femur fracture incidenceS Boriani, F De Iure, L Campanacci, et al.
Genes, Chromosomes & Cancer|September 23, 2008
Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarksSilvia Bungaro, Marta Campo Dell'Orto, Andrea Zangrando, et al.
Pageof 9